Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 USD | -1.79% | +5.21% | -15.62% |
02:00pm | Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem | CI |
03-28 | Transcript : Iterum Therapeutics plc, Q4 2023 Earnings Call, Mar 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.62% | 27.65M | |
+2.17% | 42.75B | |
+47.70% | 41.61B | |
+12.23% | 41.34B | |
-8.83% | 26.59B | |
+6.56% | 25.49B | |
-22.92% | 18.12B | |
+30.28% | 12.24B | |
-2.23% | 11.76B | |
+8.99% | 11B |
- Stock Market
- Equities
- ITRM Stock
- News Iterum Therapeutics plc
- Sector Update: Health Care